Inhibikase Therapeutics, Inc.
IKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$28 | -$19 | -$18 | -$15 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $1 | $0 | $2 |
| Change in WC | $0 | $0 | $0 | -$2 |
| Other Non-Cash | $0 | $0 | $0 | $1 |
| Operating Cash Flow | -$19 | -$18 | -$17 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$60 | -$29 | -$21 | $0 |
| Inv. Sales/Matur. | $23 | $41 | $5 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | -$37 | $12 | -$16 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$0 | -$0 |
| Stock Issued | $103 | $9 | $0 | $41 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $0 |
| Financing Cash Flow | $103 | $8 | -$0 | $41 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $47 | $2 | -$34 | $27 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9 | $7 | $41 | $14 |
| End Cash | $56 | $9 | $7 | $41 |
| Free Cash Flow | -$19 | -$18 | -$18 | -$14 |